Breaking News

Tweet TWEET

Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences

   Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of
                       Chemical & Engineering Sciences

  PR Newswire

  SINGAPORE, June 20, 2013

SINGAPORE, June 20, 2013 /PRNewswire/ --

  New programme aims to help companies increase productivity with technology
              solutions for pharmaceutical and chemical sectors

Pfizer Asia Pacific Pte. Ltd, Glaxo Wellcome Manufacturing Pte. Ltd. and
Siemens Pte. Ltd, have signed on as founding members of a new A*STAR R&D
Consortium Programme - Innovative Processing of Specialties and
Pharmaceuticals (iPSP). Launched by A*STAR's Institute of Chemical and
Engineering Sciences (ICES), the consortium offers a platform for
pharmaceutical and specialty chemicals industry players to address various
challenges such as costs, regulatory compliance and responsiveness in
production and processes to bring drugs from trials to markets.

The consortium programme brings together industry leaders to address an
increasingly urgent need to access emerging "next generation manufacturing"
technologies that provide quantum change improvements in cost, quality,
environmental impact and process robustness in pharmaceutical manufacturing
processes. The advancement in technologies and adoption of best practices in
processing technologies will help companies drive up productivity and maximise
manpower development to maintain their competitive edge.

The programme also offers a unique platform for members to interact, develop
and grow the industry processing technology knowledge base by facilitating the
technology transfer and manpower development in advanced chemical processing
technologies. The programme draws on established resources and capabilities
at ICES. These include the Kilo Scale Laboratory, pilot scale multipurpose
continuous plant, a fully equipped development laboratory and staff
experienced in process development and operation. The Institute'score skill
areas including chemistry, chemical engineering, analytics, control,
formulation science and catalysisform astrong basis for the development of
innovative manufacturing approaches. The programme will see research
activities undertaken in industrially relevant areas like process analytics
(PAT), Quality by Design (Qbd) as well as continuous manufacturing systems.

In Singapore, the chemicals and energy industries accounted for around S$100
billion or 34% of our total manufacturing output in 2012 ^[ ^1 ^] . The
chemicals and energy sectors are key pillars in Singapore's manufacturing
output. This consortium presents tremendous opportunities for companies to
extend their presence in Singapore and leverage on its position as a gateway
to Asia. It also allows them to respond with agility to the emerging needs of
Asian customers and end-consumers, through innovation or customisation of new
applications.

"ICES has built strong and deep capabilities in the understanding of process
science and technologies and the time is ripe for such depth and breadth of
knowledge to be applied to the chemicals and pharmaceutical industries. By
identifying common research focus, companies can mutually benefit from joint
research. This will enable companies to address industry-wide challenges and
further reinforce the competitiveness of Singapore's chemicals industry," said
Dr. Keith Carpenter, Executive Director, ICES. 

Bringing impact to Singapore's pharmaceutical and specialty sectors

As a leading research institute in process innovations, ICES provides easy
access to research and development resources, making a difference to corporate
organisations looking for an edge in the global marketplace and tapping into
our exciting technologies and solutions to expand beyond their home markets.

"For Singapore manufacturing business to sustain global competitiveness,
employing technological advancements in the areas of energy management and
manufacturing operations is essential. The iPSP programme provides a great
platform to move ideas in technology to real world solutions," said Mr. George
Routhier, Managing Director, Pfizer Asia Pacific Pte. Ltd.

"At a time when companies in the pharmaceutical industry are challenged on
speed in new product development, manufacturing process innovation,
consistency in product quality, regulatory conformance and environmental
sustainability, an integrative approach to the application of cutting edge
technologies will be crucial to future success. The launch of iPSP is very
timely," said Mr. Lim Hock Heng, Managing Director of GlaxoSmithKline's
Pharmaceutical Manufacturing Sites Singapore.

"The cooperation with ICES in research for innovation in process manufacturing
is a great step towards creating advance knowledge for Singapore. To be
selected as the technology partner for ICES is a great honour for Siemens in
Singapore. With our comprehensive knowledge and technology, we are sure that
we can add great value to the projects," said Mr. Matthias Gronstedt, Vice
President Sales, Industry Automation & Drive Technologies Division, Siemens
Pte. Ltd, Singapore.

^[ ^1 ^] Economic Survey of Singapore 2012

About the Institute of Chemical and Engineering Sciences (ICES)

Institute of Chemical and Engineering Sciences (ICES) is a member of the
Agency for Science, Technology and Research (A*STAR). Established in 2002, its
mission is to carry out world class scientific research, to develop novel
technology and to nurture creative scientists and engineers to support
economic growth in Singapore and to make a positive difference to society. The
research area covers chemistry and chemical engineering science, combined with
advanced analytical characterisation and measurement to develop state of the
art technology for the petrochemical, general chemical, fine chemical and
pharmaceutical industries. For more information, visit
http://www.ices.a-star.edu.sg

For technical or collaboration enquiries, please contact: Ms Tan Joo Lett,
Tel: +65-6796-3973, Email: tan_joo_lett@ices.a-star.edu.sg

For media enquiries, please contact: Ms Caroline Chia, Tel: +65-6796-3884,
Mobile: +65-91703988, Email: chialic@scei.a-star.edu.sg
 
Press spacebar to pause and continue. Press esc to stop.